- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02188485
Social Connections and Late Life Suicide
September 10, 2021 updated by: Kimberly Van Orden, University of Rochester
With the long-term goal of improving interventions for late-life suicide, the purpose of this study is to examine whether a mechanism by which behavioral interventions reduce risk for late-life suicide is by increasing social connectedness.
The investigators propose to examine whether a manualized intervention that targets connectedness--ENGAGE--increases connectedness in older adults who report clinically significant depression and disconnectedness-operationalized as feeling lonely and/or like a burden on others.
The investigators propose a randomized controlled trial comparing the ENGAGE intervention with care-as-usual (CAU), using n=100 primary care patients aged ≥ 60 years who report social disconnectedness (i.e., loneliness or burdensomeness) and either Minor or Major Depression.
At baseline, 3-week, 6-week and 10-week assessments, subjects will report on social connectedness, depression, and suicide risk.
The investigators hypothesize that those subjects assigned to ENGAGE will report greater increases in connectedness-measured as greater belongingness and lower burdensomeness-compared to CAU; that ENGAGE will produce greater reductions in depression and suicide ideation than CAU; and that changes in depression will be accounted for changes in social connectedness.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Rochester, New York, United States, 14642
- University of Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age ≥ 60 yrs;
- English speaking;
- Reside in the community;
- Endorse social disconnectedness, as measured by feeling lonely and/or like a burden on others;
- Meet criteria for Minor or Major Depression.
Exclusion Criteria:
- Imminent risk for suicide;
- Active psychosis;
- Significantly impaired cognitive functioning (i.e., MOCA <23);
- Active substance abuse in the last year (AUDIT score of 5 or more);
- Hearing loss that precludes comfortable communication;
- Residence in a long-term care facility.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ENGAGE: a social engagement intervention
ENGAGE is a brief psychotherapy that specifically targets increased social engagement and activity.
The study will use the ENGAGE manual developed by Drs.
Alexopoulos, Arean and their colleagues, focusing on increased engagement in activities that allow subjects to be social (targeting thwarted belongingness) or contribute to the well-being of others (targeting perceived burdensomeness).
|
Up to 10 sessions delivered in the home.
|
|
No Intervention: Care-as-Usual
Care as usual in primary care with study assessments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Social Connectedness
Time Frame: 10 weeks
|
Severity of social disconnectedness at 10 weeks, operationalized as thwarted belongingness and perceived burdensomeness, measured by the Interpersonal Needs Questionnaire.
Scores on the thwarted belonging subscale range from 0-18, with greater scores indicating greater thwarted belonging (i.e., worse outcome).
Scores on the perceived burden subscale range from 0-12, with greater scores indicating greater perceived burden on others (i.e., worse outcome).
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suicide Ideation
Time Frame: 10 weeks
|
Suicide ideation at 10 weeks, measured by the Geriatric Suicide ideation scale, with scores ranging from 4 to 20, with greater scores indicating greater suicide ideation (i.e., worse outcome).
|
10 weeks
|
|
Depression
Time Frame: 10 weeks
|
Depression severity was measured with the Quick Inventory of Depressive Symptomatology (QIDS), interviewer rated version, with scores ranging from 0 to 27, with higher scores indicating greater depression (worse outcomes).
|
10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kimberly A Van Orden, PhD, University of Rochester
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Van Orden, K. A., et al.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2015
Primary Completion (Actual)
May 30, 2017
Study Completion (Actual)
May 30, 2017
Study Registration Dates
First Submitted
July 2, 2014
First Submitted That Met QC Criteria
July 8, 2014
First Posted (Estimate)
July 11, 2014
Study Record Updates
Last Update Posted (Actual)
October 7, 2021
Last Update Submitted That Met QC Criteria
September 10, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- K23MH096936 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Bekelu Teka WorkuJimma UniversityNot yet recruitingPrenatal Depression | Mental Health Related Quality of Life | Maternal Postpartum Depression | Paternal Postpartum DepressionEthiopia
Clinical Trials on ENGAGE
-
University of AlbertaAlberta Health servicesRecruitingNeurodevelopmental DisordersCanada
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)Completed
-
Centre de Recherche de l'Institut Universitaire...Canadian Institutes of Health Research (CIHR); Rotman Research Institute at...Active, not recruitingSubjective Cognitive DeclineCanada
-
University of Nevada, Las VegasRecruitingMild Cognitive Impairment | Executive Dysfunction | Psychotherapy | Depression in Old AgeUnited States
-
Uniformed Services University of the Health SciencesMassachusetts General Hospital; Beth Israel Deaconess Medical Center; University... and other collaboratorsRecruitingMental Health | Resilience | Risk Reduction Behavior | Suicide Prevention | Performance at Work | Risky BehaviorUnited States
-
Mental Health Services in the Capital Region, DenmarkCNSR, Glostrup Psychiatric CenterCompletedSchizophrenia Spectrum Disorders | Negative Symptoms in SchizophreniaDenmark
-
University of PittsburghNational Center for Advancing Translational Sciences (NCATS)Terminated
-
University of MichiganCompletedKnee OsteoarthritisUnited States
-
University of Illinois at ChicagoNational Center for Advancing Translational Sciences (NCATS)RecruitingDisabilities MultipleUnited States
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)Completed